GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality Growth
- Written by PR Newswire
 |
Group Performance
- Revenue: US$959.5 million, +61.4% year-on-year
- Gross profit: US$553.2 million, +103.3% year-on-year
- Adjusted net profit: US$230.3 million, +285.0% year-on-year
Business Units' Performance
- GenScript Life Science Group (LSG): US$522.1 million, +14.8% year-on-year
- ProBio: US$388.7 million, +309.1% year-on-year
- Bestzyme: US$58.0 million,...
